Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Braude A. C., Downar E., Chamberlain D. W., Rebuck A. S. Tocainide-associated interstitial pneumonitis. Thorax. 1982 Apr;37(4):309–310. doi: 10.1136/thx.37.4.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper J. A., Jr, White D. A., Matthay R. A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis. 1986 Feb;133(2):321–340. doi: 10.1164/arrd.1986.133.2.321. [DOI] [PubMed] [Google Scholar]
- Cooper J. A., Jr, White D. A., Matthay R. A. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. Am Rev Respir Dis. 1986 Mar;133(3):488–505. doi: 10.1164/arrd.1986.133.3.488. [DOI] [PubMed] [Google Scholar]
- Horn H. R., Hadidian Z., Johnson J. L., Vassallo H. G., Williams J. H., Young M. D. Safety evaluation of tocainide in the American Emergency Use Program. Am Heart J. 1980 Dec;100(6 Pt 2):1037–1040. doi: 10.1016/0002-8703(80)90210-0. [DOI] [PubMed] [Google Scholar]
- Perlow G. M., Jain B. P., Pauker S. G., Zarren H. S., Wistran D. C., Epstein R. L. Tocainide-associated interstitial pneumonitis. Ann Intern Med. 1981 Apr;94(4 Pt 1):489–490. doi: 10.7326/0003-4819-94-4-489. [DOI] [PubMed] [Google Scholar]